MELAS Associated With a Large-Scale MT-ND2 Deletion
Open Access
- 2 November 2026
- journal article
- research article
- Published by Wolters Kluwer Health in The Neurologist
Abstract
Introduction: Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is a clinically and genetically heterogeneous mitochondrial disorder. Although the m.3243A>G variant in MT-TL1 is the most common molecular cause, atypical cases with negative routine genetic testing and nondiagnostic muscle biopsy may pose a substantial diagnostic challenge. Here, we report a clinically diagnosed MELAS case with supportive neuropathological findings and a large-scale deletion involving MT-ND2. Case Report: A 20-year-old man presented with recurrent seizures and encephalopathic episodes over 1.5 years. His clinical course was characterized by episodic visual disturbance, hearing impairment, hemiparesis, and progressive encephalopathic deterioration. Serial magnetic resonance imaging revealed recurrent migratory cortical lesions involving the occipital, temporal, and frontal lobes, and magnetic resonance spectroscopy demonstrated a lactate peak. Cerebrospinal fluid analysis and autoimmune and infectious investigations were unremarkable. Electromyography, muscle biopsy, and initial next-generation sequencing, including testing for the common m.3243A>G variant, were nondiagnostic. Subsequent brain biopsy demonstrated laminar cortical necrosis, supporting a mitochondrial encephalopathic process. Multiplex ligation-dependent probe amplification further identified a large-scale pathogenic deletion involving MT-ND2. Based on the characteristic clinical course, neuroimaging pattern, neuropathological findings, and complementary genetic analysis, a diagnosis of MELAS was established. Conclusion: This case expands the diagnostic spectrum of MELAS and highlights that typical clinical and radiologic features may still be present even when routine lactate testing, muscle biopsy, and standard genetic screening are nondiagnostic. In highly suspected cases, brain biopsy and complementary methods for mitochondrial structural variation analysis, such as MLPA, may provide crucial diagnostic evidence.Keywords
This publication has 31 references indexed in Scilit:
- Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementationNeuroradiology, 2023
- MELAS with multiple stroke‐like episodes due to the variant m.13513G>A in MT‐ND5Clinical Case Reports, 2022
- Clinical features, pathogenesis, and management of stroke-like episodes due to MELASMetabolic Brain Disease, 2021
- Pediatric Leigh Syndrome: Neuroimaging Features and Genetic CorrelationsAnnals of Neurology, 2020
- Pathological mechanisms underlying single large‐scale mitochondrial DNA deletionsAnnals of Neurology, 2018
- Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and ManagementNeurotherapeutics, 2016
- MERRF/MELAS overlap syndrome due to the m.3291T>C mutationMetabolic Brain Disease, 2013
- MERRF and Kearns–Sayre overlap syndrome due to the mitochondrial DNA m.3291T>C mutationMuscle & Nerve, 2011
- Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndromePediatric Neurology, 1995
- Mitochondrial angiopathy in cerebral blood vessels of mitochondrial eneephalomyopathyActa Neuropathologica, 1987